West Chester, OH, United States of America

Angela Jane Deutsch

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: The Procter Gamble Company, The Cleveland Clinic Foundation. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela Jane Deutsch. Retrieved from https://idiyas.com/inventor/angela-jane-deutsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 29(Granted Patents)

Company Filing History:

7 out of 17,173

The Procter Gamble Company

patents

2 out of 1,071

The Cleveland Clinic Foundation

patents

where one patent can have more than one assignee

Years Active: 2014-2020

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10786479 - Methods for inhibiting conversion of carnitine to trimethylamine (TMA) (2020-09-29),

2. 10780072 - Methods for inhibiting conversion of choline to trimethylamine (TMA) (2020-09-22),

3. 9526673 - Blister cards promoting intuitive dosing (2016-12-27),

4. 9445970 - Blister cards promoting intuitive dosing (2016-09-20),

5. 9314402 - Blister cards promoting intuitive dosing (2016-04-19),

6. 8905237 - Blister cards promoting intuitive dosing (2014-12-09),

7. 8752704 - Blister cards promoting intuitive dosing (2014-06-17),

Title: Innovations of Angela Jane Deutsch

Introduction

Angela Jane Deutsch is a notable inventor based in West Chester, Ohio. She has made significant contributions to the field of biochemistry, particularly in the area of metabolic processes. With a total of seven patents to her name, her work focuses on methods that have the potential to impact health and nutrition.

Latest Patents

Among her latest patents are innovative methods for inhibiting the conversion of carnitine to trimethylamine (TMA). This invention provides a method that involves administering specific compositions to individuals, effectively lowering TMAO levels. Another significant patent addresses the inhibition of choline conversion to TMA, offering a similar approach to reducing TMAO through the administration of effective compounds.

Career Highlights

Angela has worked with prominent organizations such as The Procter & Gamble Company and The Cleveland Clinic Foundation. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to advancements in health-related technologies.

Collaborations

Angela has collaborated with notable colleagues, including Thomas Alfred Inglin and Rosa Manuela Leon Alonso. These partnerships have fostered a collaborative environment that enhances the development of her inventions.

Conclusion

Angela Jane Deutsch's contributions to the field of biochemistry through her patents demonstrate her commitment to innovation and health improvement. Her work continues to influence the scientific community and offers promising solutions for metabolic health challenges.

Profile summary based on public USPTO records.